Abstract
AIMS: To examine the potential role of the lipolytic enzyme phospholipase A2, produced by Helicobacter pylori in ulcer formation. METHODS: Phospholipase A2 activity in H pylori was compared with that in 10 commonly occurring pathogenic bacteria. Phospholipase A2 activity and its cytotoxic metabolite, lysolecithin, in the basal gastric aspirates of 12 patients infected with H pylori were compared with those in 12 subjects not infected with H pylori. RESULTS: The phospholipase A2 activity in H pylori was substantially higher than that in most of the other bacteria tested, and the activities of phospholipase A2 and lysolecithin in the basal gastric aspirates of those infected with H pylori were significantly higher than the activities found in the basal gastric aspirates of subjects who were not infected. The lysolecithin proportion of total phospholipids in the gastric aspirates was also much higher in the infected than the non-infected group and a weak positive correlation (0.415) was found between phospholipase A2 and lysolecithin in the infected group. CONCLUSIONS: H pylori has clinically important concentrations of phospholipase A2, an enzyme capable of hydrolysing gastric mucosal phospholipids. The high values of phospholipase A2 and lysolecithin in gastric fluid from subjects with H pylori infections supports the notion that phospholipase A2 is involved in the inflammation and mucosal damage associated with peptic ulcer formation.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barnett D., Wilson G. A., Lawrence A. C., Buckley G. A. Proposed relation between expression of interleukin-2 and transferrin receptors in B lymphocyte chronic lymphocytic leukaemia. J Clin Pathol. 1987 Jul;40(7):814–814. doi: 10.1136/jcp.40.7.814. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Begemann F., Schumpelick V. Problems in duodenogastric reflux assessment, using bile acid and lysolecithin measurement. Scand J Gastroenterol Suppl. 1981;67:51–53. [PubMed] [Google Scholar]
- Bejar R., Curbelo V., Davis C., Gluck L. Premature labor. II. Bacterial sources of phospholipase. Obstet Gynecol. 1981 Apr;57(4):479–482. [PubMed] [Google Scholar]
- Blaser M. J. Gastric Campylobacter-like organisms, gastritis, and peptic ulcer disease. Gastroenterology. 1987 Aug;93(2):371–383. doi: 10.1016/0016-5085(87)91028-6. [DOI] [PubMed] [Google Scholar]
- Buck G. E. Campylobacter pylori and gastroduodenal disease. Clin Microbiol Rev. 1990 Jan;3(1):1–12. doi: 10.1128/cmr.3.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chilton F. H., Ellis J. M., Olson S. C., Wykle R. L. 1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine. A common source of platelet-activating factor and arachidonate in human polymorphonuclear leukocytes. J Biol Chem. 1984 Oct 10;259(19):12014–12019. [PubMed] [Google Scholar]
- Figura N., Guglielmetti P., Rossolini A., Barberi A., Cusi G., Musmanno R. A., Russi M., Quaranta S. Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. J Clin Microbiol. 1989 Jan;27(1):225–226. doi: 10.1128/jcm.27.1.225-226.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Giessler A. J., Bekemeier H., Hirschelmann R., Bakathir H. A. Some effects of lysolecithin in vivo and in vitro and their possible relations to the inflammatory process. Agents Actions Suppl. 1982;10:195–211. [PubMed] [Google Scholar]
- Hazell S. L., Lee A. Campylobacter pyloridis, urease, hydrogen ion back diffusion, and gastric ulcers. Lancet. 1986 Jul 5;2(8497):15–17. doi: 10.1016/s0140-6736(86)92561-4. [DOI] [PubMed] [Google Scholar]
- Johnson A. G., McDermott S. J. Lysolecithin: a factor in the pathogenesis of gastric ulceration? Gut. 1974 Sep;15(9):710–713. doi: 10.1136/gut.15.9.710. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Leunk R. D., Johnson P. T., David B. C., Kraft W. G., Morgan D. R. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J Med Microbiol. 1988 Jun;26(2):93–99. doi: 10.1099/00222615-26-2-93. [DOI] [PubMed] [Google Scholar]
- Lumb M. R., Roseblade C. K., Helmig R., Uldbjerg N., Sullivan M. H., Elder M. G. Use of a new simplified assay for phospholipase A2 to measure bacterial enzyme levels. Clin Chim Acta. 1990 Jul;189(1):39–46. doi: 10.1016/0009-8981(90)90233-i. [DOI] [PubMed] [Google Scholar]
- Marshall B. J., Langton S. R. Urea hydrolysis in patients with Campylobacter pyloridis infection. Lancet. 1986 Apr 26;1(8487):965–966. doi: 10.1016/s0140-6736(86)91060-3. [DOI] [PubMed] [Google Scholar]
- Marshall B. J., Warren J. R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984 Jun 16;1(8390):1311–1315. doi: 10.1016/s0140-6736(84)91816-6. [DOI] [PubMed] [Google Scholar]
- Pozdniakov V. S., Kuzin N. M., Liadov K. V. Metod opredeleniia lizofosfatidilkholina (lizoletsitina) v zheludochnom soke. Lab Delo. 1987;(11):839–841. [PubMed] [Google Scholar]
- Rosam A. C., Wallace J. L., Whittle B. J. Potent ulcerogenic actions of platelet-activating factor on the stomach. Nature. 1986 Jan 2;319(6048):54–56. doi: 10.1038/319054a0. [DOI] [PubMed] [Google Scholar]
- Sarosiek J., Slomiany B. L., Slomiany A., Gabryelewicz A. Lysolecithin and glyceroglucolipids in gastric secretion of patients with gastric and duodenal ulcer. Scand J Gastroenterol. 1983 Oct;18(7):935–938. doi: 10.3109/00365528309182118. [DOI] [PubMed] [Google Scholar]
- Schumpelick V., Stemme D., Begemann F. Ulkuskrankheit und duodenogastraler Reflux. Z Gastroenterol. 1983 Jan;21(1):11–20. [PubMed] [Google Scholar]
- Sidebotham R. L., Baron J. H. Hypothesis: Helicobacter pylori, urease, mucus, and gastric ulcer. Lancet. 1990 Jan 27;335(8683):193–195. doi: 10.1016/0140-6736(90)90279-e. [DOI] [PubMed] [Google Scholar]
- Slomiany B. L., Nishikawa H., Piotrowski J., Okazaki K., Slomiany A. Lipolytic activity of Campylobacter pylori: effect of sofalcone. Digestion. 1989;43(1-2):33–40. doi: 10.1159/000199858. [DOI] [PubMed] [Google Scholar]
- Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J., Klenk D. C. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985 Oct;150(1):76–85. doi: 10.1016/0003-2697(85)90442-7. [DOI] [PubMed] [Google Scholar]
- Stenson W. F. Platelet-activating factor and inflammatory bowel disease. Gastroenterology. 1988 Nov;95(5):1416–1419. doi: 10.1016/0016-5085(88)90383-6. [DOI] [PubMed] [Google Scholar]
- Takayama M., Itoh S., Nagasaki T., Tanimizu I. A new enzymatic method for determination of serum choline-containing phospholipids. Clin Chim Acta. 1977 Aug 15;79(1):93–98. doi: 10.1016/0009-8981(77)90465-x. [DOI] [PubMed] [Google Scholar]
- Thuren T., Virtanen J. A., Lalla M., Kinnunen P. K. Fluorometric assay for phospholipase A2 in serum. Clin Chem. 1985 May;31(5):714–717. [PubMed] [Google Scholar]
- Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983 Jun 4;1(8336):1273–1275. [PubMed] [Google Scholar]